QuidelOrtho (QDEL) Non-Current Deferred Tax Liability (2022 - 2026)
QuidelOrtho (QDEL) posted Non-Current Deferred Tax Liability of $87.3 million for Q1 2026, down 3.0% sequentially from $90.0 million in Q4 2025, and up 11.64% YoY from $78.2 million in Q1 2025.
QuidelOrtho (QDEL) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends
QuidelOrtho has reported Non-Current Deferred Tax Liability for 5 years, with the latest figure at $87.3 million in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability rose 11.64% year-over-year to $87.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $87.3 million (up 11.64% YoY) and the FY2025 annual result came in at $90.0 million, down 85.5% from the prior year.
- Non-Current Deferred Tax Liability retreated to $87.3 million in Q1 2026 per QDEL's latest filing, from $90.0 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $707.4 million in Q4 2023 and troughed at $73.5 million in Q1 2022.
- A 5-year average of $204.7 million and a median of $127.9 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2023 and 2025: Non-Current Deferred Tax Liability surged 231.8% in 2023, then tumbled 85.5% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $256.4 million in 2022, then surged by 175.9% to $707.4 million in 2023, then declined by 12.26% to $620.7 million in 2024, then sank by 85.5% to $90.0 million in 2025, then slipped by 3.0% to $87.3 million in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $87.3 million, $90.0 million, and $80.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | QuidelOrtho | 1.01 Bn | 884.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 122.10 Mn |
| Jun 28, 2026 | 122.10 Mn |
| Mar 29, 2026 | 87.30 Mn |
| Mar 29, 2026 | 87.30 Mn |
| Dec 28, 2025 | 90.00 Mn |
| Dec 28, 2025 | 90.00 Mn |
| Sep 28, 2025 | 80.10 Mn |
| Sep 28, 2025 | 80.10 Mn |
| Jun 29, 2025 | 82.80 Mn |
| Jun 29, 2025 | 82.80 Mn |
| Mar 30, 2025 | 78.20 Mn |
| Mar 30, 2025 | 78.20 Mn |
| Dec 29, 2024 | 620.70 Mn |
| Dec 29, 2024 | 620.70 Mn |
| Sep 29, 2024 | 117.20 Mn |
| Sep 29, 2024 | 117.20 Mn |
| Jun 30, 2024 | 127.90 Mn |
| Jun 30, 2024 | 127.90 Mn |
| Mar 31, 2024 | 125.60 Mn |
| Mar 31, 2024 | 125.60 Mn |